Efectiveness and Safety of a Generic Fixed-Dose Combination of Nevirapine, Stavudine and Lamivudine in HIV-1-infected Adults in Cameroon: Open-Label Multicentre Trial. Laurent C, Kovanfack C, Koulla-Shiro S, Nikové N Et Al. Lancet 2004; 364: 29-34

Revista Chilena de Infectologia - Chile
doi 10.4067/s0716-10182004000400013
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SciELO Agencia Nacional de Investigacion y Desarrollo (ANID)

Related search

Pharmacokinetics of Generic and Trade Formulations of Lamivudine, Stavudine and Nevirapine in HIV-infected Malawian Children

Antiviral Therapy
Infectious DiseasesPharmacology
2010English

Steady-State Pharmacokinetics of Nevirapine in HIV-1 Infected Adults in India

Journal of the International Association of Physicians in AIDS Care
2007English

Efficacy of Boceprevir, an NS3 Protease Inhibitor, in Combination With Peginterferon Alfa-2b and Ribavirin in Treatment-Naive Patients With Genotype 1 Hepatitis C Infection (SPRINT-1): An Open-Label, Randomised, Multicentre Phase 2 Trial

The Lancet
Medicine
2010English

A Multicentre Open-Label Safety and Efficacy Study of Tetrodotoxin for Cancer Pain

Current Oncology
Oncology
2011English

Pin65 - Budget Impact Analysis of the Fixed Dose Combination Phosphazide/Lamivudine Antiretroviral Drug for Hiv Treatment in Russa

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Combination Therapy With Stavudine (D4T), Didanosine (ddI), and Indinavir in HIV-Infected Children • 727

Pediatric Research
Child HealthPediatricsPerinatology
1997English

Population Pharmacokinetics of Nevirapine in HIV-1-Infected Pregnant Women and Their Neonates

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2010English

A Prospective and Open Label Study of Use of Cilnidipine and Chlorthalidone Fixed Dose Combination in Indian Hypertensive Patients, Intolerant or Uncontrolled on Amlodipine and Hydrochlorothiazide Combination

International Journal of Advances in Medicine
2017English

Phase I Safety and Immunogenicity Evaluations of an Alphavirus Replicon HIV-1 Subtype C Gag Vaccine in Healthy HIV-1-Uninfected Adults

Clinical and Vaccine Immunology
MedicineImmunologyAllergyClinical BiochemistryMicrobiology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy